We will be performing system updates on Sunday, July 21st, from 9-noon ET. You may experience brief service interruptions during that time.
Browse Prior Art Database

Process for the preparation of Novel cabazitaxel Anisole Solvate

IP.com Disclosure Number: IPCOM000246330D
Publication Date: 2016-May-31

Publishing Venue

The IP.com Prior Art Database

Related People

Dr. Madhuresh Kumar Sethi [+details]

Related Documents

Other References:
cabazitaxel - IP.COM [+details]


Cabazitaxel is a semi synthetic taxoid derivative, used in combination with prednisone for the treatment of patients with castration-resistant metastasis, whose disease progresses after docetaxel treatment. Many solvates of Cabazitaxel have been published in patents. Different solvates may result in different physical properties. Thus, discovery of novel solvates yields an opportunity for further improvement of advantageous properties. The present disclosure relates to the preparation of cabazitaxel anisole solvate